Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.61 |
| ▸ | MAOA | P21397 | 3/20 | 0.61 |
| ▸ | BACE1 | P56817 | 2/20 | 0.61 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.55 |
| ▸ | RELA | Q04206 | 3/20 | 0.55 |
| ▸ | PDE4A | P27815 | 1/20 | 0.54 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.54 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.54 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.54 |
| ▸ | AURKA | O14965 | 1/20 | 0.53 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30383246 | 1.00 | MAOB (0.61) | MAOBMAOABACE1ABCG2ACHE | |
| SCHEMBL30384157 | 1.00 | MAOB (0.61) | MAOBMAOABACE1ABCG2ACHE | |
| SCHEMBL16098173 | 1.00 | MAOB (0.61) | MAOBMAOABACE1ABCG2ACHE | |
| SCHEMBL31088177 | 0.93 | BACE1 (0.56) | MAOBMAOABACE1ABCG2ACHE | |
| SCHEMBL31088175 | 0.93 | BACE1 (0.56) | MAOBMAOABACE1ABCG2ACHE | |
| SCHEMBL16490919 | 0.87 | MAOB (0.74) | MAOBMAOAABCG2ACHECYP3A4 | |
| SCHEMBL30384092 | 0.87 | MAOB (0.74) | MAOBMAOAABCG2ACHECYP3A4 | |
| SCHEMBL30383843 | 0.87 | MAOB (0.74) | MAOBMAOAABCG2ACHECYP3A4 | |
| SCHEMBL19182752 | 0.87 | MAOB (0.74) | MAOBMAOAABCG2ACHECYP3A4 | |
| SCHEMBL31088178 | 0.85 | ABCG2 (0.69) | MAOBMAOAABCG2CYP3A4NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| US-20250134146-A1 | FLAVANONE COMPOUNDS AND THEIR USE AS FLAVOR MODIFIERS | FIRMENICH INCORPORATED (US) | 2025-05-01 | — | — | US | disclosed |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| EP-2984077-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING SWEET TASTE | Chromocell Corporation (US) | 2016-02-17 | — | — | EP | disclosed |
| US-20160015064-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING SWEET TASTE | CHROMOCELL CORPORATION (US) | 2016-01-21 | — | — | US | disclosed |
| US-20150050410-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING SWEET TASTE | CHROMOCELL CORPORATION (US) | 2015-02-19 | — | — | US | disclosed |
| WO-2014153000-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING SWEET TASTE | CHROMOCELL CORPORATION (US) | 2014-09-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150050410-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING SWEET TASTE | TAS2R5, TAS2R20, TAS2R10 | MAOB 4493/4885MAOA 4572/4885BACE1 3415/4885 |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | MAOB 1004/4885MAOA 1902/4885BACE1 712/4885 |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | MAOB 2435/4885MAOA 3145/4885BACE1 1486/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | MAOB 2435/4885MAOA 3145/4885BACE1 1486/4885 |
| US-20160015064-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING SWEET TASTE | TAS2R5, TAS2R20, TAS2R10 | MAOB 4493/4885MAOA 4572/4885BACE1 3415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.